FTSE 100 news / Companies and sectors / Haleon / 13 October 2026

Haleon (HLN): news on Tuesday 13 October 2026

+2.3 slightly positive

Coverage mixed a run of share price gains and several brand campaigns for Excedrin and Robitussin with a UBS view that Haleon may dial back its FY26 growth target. The share momentum and marketing news lean positive, but the possible target cut limits the upside.

What drove it

share price rally
brand campaigns
UBS growth target view

The 7 stories

Each headline's own score, strongest first. Links go to the publisher.

+7.5 Haleon Shares Rise for a Seventh Straight Session AskTraders.com
Shares up seven sessions in a row; positive momentum.
−7.5 UBS Thinks Haleon May Dial Back Its FY26 Growth Target Finimize
UBS expects Haleon may lower its FY26 growth target.
+6.7 Why Does Haleon (LSE:HLN) Keep Rising In [FTSE 100] Sessions This Week? Kalkine Media
Shares keep rising in FTSE 100 sessions this week.
+3.3 Haleon and Publicis LeONE Introduce Robby Tussin in New Campaign "Take Care of Your Cough" Roastbrief US
New Robitussin marketing campaign with Publicis; brand support.
+2.5 Haleon (LSE:HLN) Draws Fresh Attention As Excedrin Campaign Puts Valuation Back In Focus Simply Wall Street
Excedrin campaign draws attention to Haleon valuation; mildly positive.
+2.5 Only Excedrin Brings Digital Pet Nostalgia Back with a Headache You Can't Ignore PR Newswire
Excedrin nostalgia campaign launch; mild brand positive.
+2.5 Take care of your cough with Robitussin Shots
Robitussin cough campaign coverage; modest brand promotion.

Haleon: every day · Pharma and healthcare on 13 October 2026 · FTSE 100 overview for the day